Comcast working on its own voice technology for in-home monitoring

Amy Baxter | | Health Exec | Economics

Comcast is venturing into the health business with a new technology that aims to monitor people’s health at home, CNBC reported. The device has been likened to Amazon’s AI-powered voice technology Alexa.

However, unlike Amazon’s Alexa, Comcast’s device won’t be meant to be used as a communications or assistant tool. Like Alexa, it will have a personality and have the ability to make emergency phone calls for people if a health event is occurring.

Reportedly, Comcast is planning to pilot the system this year, with the intention to roll out the system next year. Comcast is already talking with hospitals to take on shared savings if the device can keep people out of the hospital, CNBC reported, citing people familiar with the matter.

See the full story below:

Comcast is working on an in-home device to track people’s health

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.